Zulfa Omer
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL (NCT07014917) | Zulfa Omer | 2025-12-05 |
| Study of Epcoritamab as a Consolidation Therapy in CLL/SLL (NCT07108998) | Zulfa Omer | 2025-08-22 |
| LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This (NCT06978088) | Zulfa Omer | 2025-06-01 |
Track Zulfa Omer automatically
Every clearance here is in the API, with alerts when new ones post.